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Abstract. 
 
The GTP-binding protein ADP-ribosylation
factor 6 (Arf6) regulates endosomal membrane traf-
ﬁcking and the actin cytoskeleton in the cell periphery.
GTPase-activating proteins (GAPs) are critical regula-
tors of Arf function, controlling the return of Arf to the
inactive GDP-bound state. Here, we report the identiﬁ-
cation and characterization of two Arf6 GAPs, ACAP1
and ACAP2. Together with two previously described
Arf GAPs, ASAP1 and PAP, they can be grouped into a
protein family deﬁned by several common structural
motifs including coiled coil, pleckstrin homology, Arf
GAP, and three complete ankyrin-repeat domains.
All contain phosphoinositide-dependent GAP activity.
ACAP1 and ACAP2 are widely expressed and occur to-
gether in the various cultured cell lines we examined.
Similar to ASAP1, ACAP1 and ACAP2 were recruited
to and, when overexpressed, inhibited the formation of
platelet-derived growth factor (PDGF)–induced dorsal
membrane rufﬂes in NIH 3T3 ﬁbroblasts. However, in
contrast with ASAP1, ACAP1 and ACAP2 functioned
as Arf6 GAPs. In vitro, ACAP1 and ACAP2 preferred
Arf6 as a substrate, rather than Arf1 and Arf5, more so
than did ASAP1. In HeLa cells, overexpression of ei-
ther ACAP blocked the formation of Arf6-dependent
protrusions. In addition, ACAP1 and ACAP2 were re-
cruited to peripheral, tubular membranes, where acti-
vation of Arf6 occurs to allow membrane recycling
back to the plasma membrane. ASAP1 did not inhibit
Arf6-dependent protrusions and was not recruited by
Arf6 to tubular membranes. The additional effects of
ASAP1 on PDGF-induced rufﬂing in ﬁbroblasts sug-
gest that multiple Arf GAPs function coordinately in
the cell periphery.
Key words: actin • ADP-ribosylation factor • GTP-
ase-activating proteins • membrane trafﬁc • pleckstrin
homology domain
 
Introduction
 
The ADP-ribosylation factors (Arfs)
 
1
 
 are a family of ubiq-
uitous and highly conserved GTP-binding proteins in eu-
karyotes (for reviews see Donaldson and Klausner, 1994;
Donaldson et al., 1995; Moss and Vaughan, 1995, 1998).
Based on biochemical activities and sequence similarity,
proteins within the Arf family can be divided into Arf and
Arf-like proteins. The Arf proteins have been further sub-
divided into class I (Arf1, Arf2, and Arf3), class II (Arf4
and Arf5), and class III (Arf6) Arfs. Similar to other GTP-
binding proteins, Arfs function as molecular switches with
multiple targets affecting a variety of cellular events. Arfs
regulate membrane traffic (Donaldson and Klausner, 1994;
Donaldson et al., 1995; Moss and Vaughan, 1995, 1998)
and the actin cytoskeleton (Radhakrishna et al., 1996,
1999; D’Souza-Schorey et al., 1997; Frank et al., 1998; Song
et al., 1998; Franco et al., 1999; Zhang et al., 1999), and di-
rectly stimulate phospholipase D and phosphatidylinositol
4-phosphate 5-kinase (Brown et al., 1993; Cockcroft et al.,
1994; Honda et al., 1999). Multiple Arf family members
may function in the same membrane trafficking system,
and Arf1 and 6 impinge on the actin cytoskeleton in the
cell periphery. Arf6 affects membrane ruffling, filopodia,
and actin-rich protrusions; Arf1 affects focal adhesions
(Radhakrishna et al., 1996; Frank et al., 1998; Norman et
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Abbreviations used in this paper:
 
 AlF4, tetrafluoroaluminate; ANK,
ankyrin; Arf, ADP-ribosylation factor; EST, expressed sequence tag;
GAP, GTPase-activating protein; GEF, guanine nucleotide exchange fac-
tor; PA, phosphatidic acid; PDGF, platelet-derived growth factor; PH,
pleckstrin homology; PIP2, phosphatidylinositol 4,5-bisphosphate. 
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al., 1998; Franco et al., 1999). In addition, a single Arf fam-
ily member may fulfill the same or similar functions at mul-
tiple sites in the same pathway. For instance, Arf1 regu-
lates membrane traffic from the ER through the Golgi
complex and from the trans-Golgi network (Balch et al.,
1992; Donaldson et al., 1992; Palmer et al., 1993; Stamnes
and Rothman, 1993; Traub et al., 1993; Ooi et al., 1998).
Similarly, Arf6 affects the formation of actin-rich mem-
brane protrusions (Radhakrishna et al., 1996; Frank et al.,
1998), rac-induced ruffles (Radhakrishna et al., 1999), and
phagosomes (Zhang et al., 1998, 1999). The presence of
multiple Arfs at a given site and single Arf isoforms at mul-
tiple sites suggest that the regulation of Arf activity is spe-
cific both for the given Arf isoform and for the compart-
ment in which the Arf is located.
Regulation that is specific for both Arf isoform and in-
tracellular site is most likely achieved through guanine nu-
cleotide exchange factors (GEFs) and GTPase-activating
proteins (GAPs). Four families of GEFs have been identi-
fied: GBF, BIG1/2, ARNO, and EFA6 (Morinaga et al.,
1997; Frank et al., 1998; Klarlund et al., 1998; Claude et al.,
1999; Franco et al., 1999; Mansour et al., 1999; Togawa et
al., 1999; Jackson and Casanova, 2000). Five mammalian
proteins have been reported to have Arf GAP activity:
Arf GAP1, GIT1/CAT1, GIT2/CAT2, PAP, and ASAP1
(Cukierman et al., 1995; Brown et al., 1998; Premont et al.,
1998; Andreev et al., 1999; Vitale et al., 2000). Compart-
ment and substrate specificity have been established for
some of these proteins. Two, GBF1 and BIG1/2, are
Golgi-localized GEFs specific for class I and II Arfs
(Claude et al., 1999; Mansour et al., 1999; Morinaga et al.,
1997; Togawa et al., 1999). ARNO and EFA6 family GEFs
function in the cell periphery, affecting membrane traffic
and the actin cytoskeleton by regulating Arf6 activity
(Frank et al., 1998; Klarlund et al., 1998; Franco et al.,
1999; Jackson and Casanova, 2000). Of the Arf GAPs, in
vitro analysis has revealed that Arf GAP1, ASAP1, and
PAP use Arf1 and Arf5 more efficiently than Arf6 (Ran-
dazzo, 1997b; Brown et al., 1998; Andreev et al., 1999),
whereas GIT1 has no preference among Arf1, 5, and 6
(Vitale et al., 2000). The in vivo Arf specificities of these
GAPs have not yet been determined. The GAPs, like the
GEFs, have distinct sites of action. Arf GAP1 specifically
affects Golgi function (Aoe et al., 1997). ASAP1 functions
in the periphery, regulating focal adhesion turnover and
reorganization of the actin cytoskeleton (Randazzo et al.,
2000a). PAP (PAG3) binds to paxillin, impacting cytoskel-
eton organization, and colocalizes with Arf6 in the cell pe-
riphery, though it does not affect Arf6-dependent cyto-
skeletal changes (Kondo et al., 2000). These data support
the hypothesis that Arf GEFs and Arf GAPs act at specific
cellular locations. However, the ability of GEFs and/or
GAPs, at a particular cellular location, to discriminate be-
tween Arfs and/or distinct Arf-dependent events has not
been examined through direct comparison of the proteins.
Here, we have identified two Arf GAPs, which we call
ACAP1 and ACAP2, that can be grouped with PAP and
ASAP1 as a family based on structural and functional ho-
mologies. We examined the in vitro GAP activities, in vivo
activities, and the localization of ACAP1, ACAP2, and
ASAP1. Although all functioned in the cell periphery, af-
fecting the actin cytoskeleton, and colocalized with Arf6,
ACAP1 and ACAP2, but not ASAP1, specifically affected
Arf6-dependent events. We propose a model in which
multiple Arf GAPs coordinate distinct events occurring
within a biological pathway. With the number of potential
Arf GAPs, these results could extrapolate to Arf function
in other compartments.
 
Materials and Methods
 
Plasmids
 
ACAP1/KIAA0050 cDNA was obtained from Dr. Takahiro Nagese at the
Kazusa DNA Research Institute (Chiba, Japan). ACAP2 was cloned from
a SuperScript human leukocyte cDNA library (Life Technologies) using a
2-kb KpnI fragment from KIAA0041 (Dr. Takahiro Nagese) as a probe.
Six positive clones were isolated, sequenced, and found to overlap over a
region of 3,227 bp. An open reading frame extends from nucleotide 61–
2,397 and encoded a predicted protein of 778 amino acids. The sequence
was entered into Genbank/EMBL/DDBJ under accession no. AJ238248,
under the name centaurin 
 
b
 
2 (available at http://www.ncbi.nim.nih.gov/
BLAST/). A mammalian expression vector for epitope-tagged ACAP1
was generated by PCR with oligonucleotide primers incorporating BstZI
and SalI sites. After digestion, the PCR product was ligated into the NotI
and SalI sites of pFLAG-CMV2 to give an in frame fusion between
ACAP1 and the NH
 
2
 
-terminal FLAG tag. For ACAP2, two overlapping
clones encompassing the open reading frame were used to amplify over-
lapping 5
 
9
 
 and 3
 
9
 
 fragments, the former contained a NotI site, the latter
contained a KpnI site. The products were purified, mixed in equimolar
amounts, and used as template for combinatorial PCR. The resulting
product was purified and digested with NotI and KpnI and subcloned into
pFLAG-CMV2 (Randazzo et al., 2000b). A FLAG-tagged ASAP1b has
been described (Brown et al., 1998). ASAP1b was also cloned into
pFLAG-CMV (Sigma-Aldrich) using the EcoRI site. The results using
this construct were identical to those using the previously described con-
struct. Glutamine mutations in arginine 448 of ACAP1 and arginine 442
of ACAP2 were introduced using a kit (Quikchange; Stratagene). The ex-
pressed proteins with these point mutations lacked GAP activity (see Re-
sults), which is consistent with the lack of activity of mutants of ASAP1
(Randazzo et al., 2000a) and PAP (Mandiyan et al., 1999) that had the
equivalent arginine mutated.
 
Determination of Tissue Distribution of mRNAs
 
Tissue cDNA panels were obtained from CLONTECH Laboratories Inc.
Primers that would yield 
 
z
 
500-bp PCR products were designed. For
ACAP1, the forward primer was CCTTCAgTCAggCTCgCCTT gAT-
gAC, the reverse primer was CCTCgAATCT CAggCAgCTT ggTCAg,
and the product was predicted to be 498 bp. For ACAP2, the forward
primer was CATCTCCATC CACAggAAgC CTAgATTCTg, the reverse
primer was TgAACTTTgg gCAgATgCTC TgACTTggTC, and the prod-
uct was predicted to be 537 bp. Conditions for thermal cycling were from
the manual from CLONTECH Laboratories Inc. that accompanied the
cDNA panels. PCR products were fractionated on a 1% agarose gel and
stained with ethidium bromide. The data shown are for 38 cycles for
ACAP1 and 34 cycles for ACAP2. Glyceraldehyde 3-phosphate dehy-
drogenase was used as a control target using primers provided by CLON-
TECH Laboratories Inc. The product obtained with 30 cycles is shown.
 
Proteins
 
FLAG-tagged ACAP1, ACAP2, and ASAP1 were expressed in COS7 or
HEK 293 cells by transient transfection using Fugene 6 (Roche). The cells
were lysed in 20 mM Tris-HCl, pH 8.0, 25 mM NaCl, containing 1% Tri-
ton X-100, complete protease inhibitor cocktail (Roche), and 10% glyc-
erol. The proteins were sequentially fractionated by anion exchange on a
HiTrap Q column (Amersham Pharmacia Biotech) in a NaCl gradient and
by chromatography on an Econo-Pac CHT-II column (Bio-Rad Laborato-
ries) in a KPi gradient (Randazzo et al., 2000b). Less than 1% of the activ-
ity in these preparations was due to endogenous GAPs that copurified
with the ectopically expressed protein (based on GAP activity in similar
fractions obtained from cells transfected with an empty vector). Native
ASAP1 was purified from bovine brain through the hydrophobic interac-
tion column step (Randazzo, 1997b; Brown et al., 1998).
 
Assays of Cellular Activities
 
Cells were maintained in DME with 10% FBS. The effects of the ACAPs
on platelet-derived growth factor (PDGF)–induced ruffling were measured 
Jackson et al. 
 
ACAPs Are Arf6 GAPs
 
629
 
using NIH 3T3 fibroblasts. The cells were transiently transfected with the
plasmids directing expression of FLAG-tagged ACAPs using Fugene 6
(Roche). 24 h after transfection, the cells were removed from the culture
plates using trypsin/EDTA and replated on fibronectin-coated coverslips
(Randazzo et al., 2000a) in serum free OptiMEM (GIBCO BRL). Cells
were incubated 5–7 h in serum-free medium followed by a 4–5-min treat-
ment with 10 ng/ml PDGF (recombinant BB; GIBCO BRL) before fixa-
tion. Transfected cells were identified by immunostaining for the FLAG
tag. Actin was visualized using rhodamine–conjugated phalloidin (Molecu-
lar Probes). Arf6-dependent changes in the actin cytoskeleton were mea-
sured in HeLa cells as described previously (Radhakrishna et al., 1996).
 
Immunofluorescence
 
Cells were prepared for immunofluorescence as described previously
(Radhakrishna et al., 1996). PDGF-induced ruffling experiments were an-
alyzed by epifluorescence microscopy. Arf6-dependent effects were visu-
alized by confocal microscopy using a ZEISS LSM 510 confocal micro-
scope with a Planapo 63
 
3
 
/1.3 NA objective. Adobe Photoshop
 
®
 
 software
was used to prepare figures from the digitized images obtained with the
confocal microscope.
 
Sequence Analysis
 
Pleckstrin homology (PH)–, Arf GAP-, and ankyrin (ANK)-repeat do-
mains were identified with the program Pfam run at the Sanger Center and
with ProfileScan run on the ISREC server. As described previously, the
predicted ANK repeats agree, to a large extent, with the published struc-
ture for the Arf GAP- and ANK-repeat domains of PAP (Mandiyan et al.,
1999). Coiled coils were identified with the program COILS (Lupas et al.,
1991), which was accessed through the ExPASy Molecular Biology Server
of the Swiss Institute for Bioinformatics and run with the MTIDK matrix.
A 28-residue window was used to detect potential coiled-coil domains and
a 21-residue window was used to identify the ends. A probability of 0.6
with less than a 25% change with weighting was used as a cutoff. ACAP1
and ACAP2 sequences were aligned using the GAP module within a GCG
run on the National Center for Biotechnology Information (NCBI) server.
Multiple alignments were performed by ClustalW on the NCBI server.
 
Antibodies
 
mAb M5 to the FLAG epitope was from Sigma-Aldrich. Fluorescein
isothiocyanate (FITC)-donkey anti–mouse, FITC-conjugated donkey
anti–rabbit, and rhodamine–conjugated goat anti–mouse antibodies were
from Jackson ImmunoResearch. Alkaline phosphatase–conjugated don-
key anti–rabbit and alkaline phosphatase–conjugated donkey anti–mouse
antibodies were from Bio-Rad Laboratories. Rabbit antiserum to the
COOH-terminal peptide of Arf6 is described in Song et al. (1998). Rabbit
antiserum 642 against ASAP1 is described in Randazzo et al. (2000a).
Rabbit antisera J150 and J151 against residues 722–740 and 1–14 of
ACAP1 conjugated via an additional NH
 
2
 
-terminal cysteine, or a COOH-
terminal tyrosine residue to PPDT (purified protein derivative of tubercu-
lin) and rabbit antiserum J149 against residues 761–778 of ACAP2 conju-
gated to an additional NH
 
2
 
-terminal cysteine residue to PPDT were raised
according to a standard booster immunization protocol (Hammonds-Odie
et al., 1996).
 
Miscellaneous
 
GAP assays were performed as described previously (Randazzo, 1997a,b).
Lipids were from Sigma-Aldrich and were used as mixed micelles with
Triton X-100 in GAP assays. Western blotting was performed using en-
hanced chemiluminescence for visualization.
 
Results
 
The ACAPs Are Members of a Highly Conserved 
Protein Family in Multicellular Organisms
 
To identify additional phosphoinositide-dependent Arf
GAPs, we searched existing cDNA databases for pre-
dicted proteins with a similarity to ASAP1 and PAP. Two
cDNAs were identified: KIAA0050 (sequence data avail-
able from EMBL/GenBank/DDBJ accession no. D30758),
which was a full-length clone, and KIAA0041 (accession
no. D26069), which lacked an initiating methionine. Fur-
ther screening of a lymphocyte library led to the identifica-
tion of the full-length cDNA (accession no. CAB41450)
for KIAA0041. The predicted proteins are similar to
ASAP1 and PAP in the amino acid sequence of the Arf
GAP domain (Brown et al., 1998) and in the relative posi-
tion of four domains, containing, in order from the NH
 
2
 
terminus: coiled coil, PH, Arf GAP, and ANK-repeat do-
mains. The expressed proteins contained phosphoinosi-
tide-dependent GAP activity (see below). We have called
KIAA0050, ACAP1, and CAB41450, ACAP2, for Arf
GAP with coiled coil, ANK repeat and PH domains.
Based on structural and biochemical considerations, we
propose that ASAP1, PAP, and the ACAPs comprise a
family. (These proteins have previously been called cen-
taurins [Randazzo et al., 2000b] because of sequence simi-
larity to centaurin 
 
a
 
. However, whereas centaurin 
 
a
 
 binds
PIP3 and lacks GAP activity, ACAP1 and ACAP2 are
preferentially activated by phosphatidylinositol 4,5-bis-
phosphate [PIP2; not shown] and do contain GAP activity.
Therefore, to avoid confusion, we have chosen “ACAP”
as a name that reflects both the enzymatic activity and
structure of the proteins.)
The ACAPs have various features that distinguish them
from ASAP1 and PAP. The amino termini of ACAP1 and
ACAP2 are similar to that of oligophrenin-1 (23% identity
for both, 37% similarity with ACAP2) (Fig. 1) and contain
coiled-coil domains within the 45 residues in the NH
 
2
 
-ter-
minal. In contrast, although the first 330 amino acids of
PAP and ASAP1 are 70% identical to each other (Brown
et al., 1998), they are 
 
,
 
25% identical to ACAP1 and
ACAP2 and the predicted coiled-coil domains are on the
NH
 
2
 
 terminus of the PH domains. Similarly, the PH do-
mains of these four proteins fall into two distinct groups,
with 
 
.
 
70% identity between ACAP1 and ACAP2 and be-
tween PAP and ASAP1, but 
 
,
 
20% identity when com-
paring ACAP1 or 2 with either PAP or ASAP1 (Fig. 1).
Furthermore, as noted previously (Brown et al., 1998; An-
dreev et al., 1999), PAP and ASAP1 contain proline-rich
domains that interact with SH3 domains of Src and Crk,
and SH3 domains that interact with FAK family members.
ACAP1 and ACAP2 lack these domains. The ACAPs
each have an additional recognizable sequence motif.
ACAP1 has homology to the PI-PLC X-box at residues
76–142. ACAP2 contains a second coiled-coil domain that
correlates to the position within the protein to the coiled-
coil domains found in PAP and ASAP1.
ASAP/ACAP family proteins occur in multicellular or-
ganisms. ACAP orthologs are found in 
 
Caenorhabditis ele-
gans
 
 (sequence data available from EMBL/GenBank/
DDBJ accession no. AJ132698 and AJ132699), 
 
Dro-
sophila melanogaster
 
 (accession no. AA803046 and
AE003742), and 
 
Arabidopsis thaliana
 
 (GCP1, accession
no. AJ130878). A PAP/ASAP1 ortholog is found in 
 
D.
melanogaster
 
 (accession no. AC008370). No orthologs of
ASAP/ACAP family proteins were found in
 
 Saccharomy-
ces cerevisiae
 
. Among mammals, the proteins are highly
conserved. For instance, mouse expressed sequence tags
(ESTs) have been identified that are 95% identical over
the translated region to human ACAP1 and ACAP2. Hu-
man and mouse PAP are 95% identical (Andreev et
al., 1999), as are mouse (Brown et al., 1998; accession
no. AF075461), human (accession no. AB033075 and
KIAA1249), and bovine (King et al., 1999; accession no.
AF112886) ASAP1. 
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ACAPs are widely expressed. PAP and ASAP1 have
been shown previously to be ubiquitously expressed
(Brown et al., 1998; Andreev et al., 1999). Message for
ACAP1 and ACAP2 was detected by PCR using cDNAs
prepared from different tissues as templates, and primers
specific for ACAP1 and ACAP2 were designed to yield
500-bp products (Fig. 2 A). The relative abundance of
message for ACAP1 varied. Of the tissues examined, the
highest levels were found in spleen and lung. Message was
also detected in heart, kidney, liver, and pancreas. Little or
no signal was detected in testis or brain. Two additional
PCR products 
 
z
 
50 and 100 bp larger than the major prod-
uct were observed in spleen, lung, and pancreas. A search
of the EST data base also revealed that ACAP1 was ex-
pressed in multiple tissues (Fig. 2 B). The ACAP2 mes-
sage was at similar levels in all tissues examined and was
found in ESTs from multiple tissues (Fig. 2). Consistent
with the distribution of message, ACAP2 and ASAP1 pro-
tein, detected by Western blotting, were found in all cell
lines examined, and ACAP1 was detected in most cells ex-
amined (Fig. 2 C). The three proteins occurred together in
CHO (not shown), HeLa, Jurkat, C1R, JY, Daudi, B,
HEK 293, and NIH 3T3 cells. Monocytes contained
ACAP2 and ASAP1, with no detectable ACAP1.
 
ACAPs Are Arf6 GAPs Dependent on PIP2 and 
Phosphotidic Acid for Activity
 
GAP activity of epitope-tagged ACAP1, ACAP2, and
ASAP1 was determined using Arf1, 5, and 6, representatives
from each class of Arf, as substrate (Fig. 3). ACAP1 used
Arf6 about twice as efficiently as Arf1 and Arf5. ACAP2
used Arf6 about fivefold better than Arf1 and Arf5. In con-
trast, ASAP1 used Arf1 and Arf5 10–100-fold more effi-
ciently than Arf6 (Fig. 3) (Brown et al., 1998). The GAP ac-
tivity reported in Fig. 3 is normalized to the amount of Arf
GAP protein, quantified through Western blotting, to the
epitope tag each of these purified proteins contained. ASAP1
had a much higher specific activity than either ACAP1 or 2 in
these in vitro assays (note the scale on GAP activity).
ACAP GAP activity was dependent on phospholipids
(Fig. 4). In previous studies, the GAP activity of ASAP1 was
found to be stimulated by the coordinate binding of PIP2
and phosphatidic acid (PA) (Randazzo, 1997b). ACAP1 and
ACAP2 showed similar phospholipid dependencies when
Arf6 was used as a substrate. In both cases, half-maximal ac-
tivity was achieved with 10–20 
 
m
 
M PIP2 in the presence of
380 
 
m
 
M PA. PAP is also comodulated by PIP2 and PA (not
shown). PA/PIP2-dependent GAP activity appears to be a
defining feature of the ASAP/ACAP family of proteins.
Figure 1. Structure of
ACAP1 and ACAP2. (A)
Comparison of primary se-
quence and structural do-
mains. The sequence of
ACAP1 and ACAP2 were
aligned using the program
GAP in GCG. Structural
domains were identified us-
ing Pfam, ProfileScan, and
COILS. Sequence that is
shaded gray is homologous
to oligophrenin-1. Sequence
comprising coiled coil, PH,
Arf GAP, and ANK-repeat
domains is indicated by
green, red, bold italic, and
dark blue text, respectively.
Homology to the PI-PLC
X-box is indicated by light
blue text. (B) Schematic of
ASAP/ACAP family mem-
bers. The “X Box” refers to
the PI-PLC X-box. “Pro” re-
fers to a proline-rich domain
with SH3-binding sites.
“E/DLPPKP” is a domain of
tandem repeats of this con-
sensus sequence. (C) Com-
parison of ASAP/ACAP
family protein PH domains.
The sequences were aligned
using ClustalW. Identities
between ACAP1 and
ACAP2 are indicated in
yellow, between PAP and
ASAP1 in blue, and common
identities in green. (D) Com-
parison of ACAP1 and
ACAP2 to oligophrenin-1.
The sequences were aligned
using ClustalW. 
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A highly conserved arginine is critical for Arf GAP activ-
ity. All proteins known to have Arf GAP activity contain an
arginine five residues on the COOH-terminal from the
fourth cysteine constituting the zinc finger. ASAP1, PAP,
and Arf GAP1, containing a mutation in this residue, have
little or no detectable GAP activity (Mandiyan et al., 1999;
Randazzo et al., 2000a; Szafer et al., 2000). ACAPs were
similar. [R448Q]ACAP1 and [R442Q]ACAP2 had no de-
tectable activity using Arf6 as a substrate (Fig. 5).
 
ACAPs Affect the Actin Cytoskeleton
 
NIH 3T3 fibroblasts treated with PDGF form actin-rich
dorsal ruffles. Examples of these unique structures are in-
dicated with arrowheads in Fig. 6. ASAP1 localizes to ac-
tin-rich dorsal ruffles and overexpression of ASAP1 inhib-
its the formation of these ruffles (Randazzo et al., 2000a).
ACAPs were similar to ASAP1. Overexpression of either
ACAP inhibited the formation of PDGF-induced dorsal
ruffles (Figs. 6 and 7, first and third rows), and the ACAPs
were recruited to those ruffles that did form (not shown).
The effects of ACAPs on ruffling were partly dependent
on GAP activity. GAP-deficient ACAP1 and ACAP2 had
less of an effect than wild-type protein, but still decreased
the rate of ruffling compared with the empty vector con-
trol (Fig. 7). In contrast, expression of a GAP-deficient
ASAP1 enhanced ruffle formation (Fig. 7). The mutant
ACAPs, like mutant ASAP1, were efficiently recruited to
the actin-rich ruffles (Fig. 6, rows 2 and 4, arrowheads).
Like ASAP1, ACAPs specifically affected Arf function in
the cell periphery. Neither ACAP1, ACAP2, nor ASAP1
(Brown et al., 1998) caused changes in the morphology of
the Golgi apparatus (not shown).
Figure 2. Expression of
ACAP1 and ACAP2. (A)
Tissue distribution. Message
levels in human tissues were
compared by semiquantita-
tive PCR, as described in
Materials and Methods.
Message for glyceralde-
hyde 3-phosphate dehydrog-
enase (G3PDH) was used as
a control. (B) ESTs encoding
ACAPs. The sequence of
ACAP1 and ACAP2 were
used to perform a BLAST
search of the EST database.
Nucleotide sequence encod-
ing identical proteins are
listed with tissue source and
accession no. (C) Compari-
son of relative protein lev-
els in cultured cell lines.
ACAP1, ACAP2, and
ASAP1 were detected by
Western blot using antibod-
ies described in Materials
and Methods. Arf6 and tubu-
lin were used as controls for
normalization.
Figure 3. Arf specificity of ACAP GAP activity.
Arf GAP assays were performed using epitope-
tagged ACAP1, ACAP2, and ASAP1 expressed
in HEK 293 cells and purified as described in
Materials and Methods. Reactivity to Arf GAP
epitope tags were used to quantify the proteins.
Arf1, 5, and 6 were used in a reaction that in-
cluded 90 mM PIP2, 380 mM PA, and either
ACAP1, ACAP2, or ASAP1. Arf GAPs were
added in quantities to give reaction rates be-
tween 0.025 and 0.25 hydrolyses/min. The data
are normalized for the amount of GAP added.
The data are representative of two experiments,
and the error bars are the range of duplicates.
Similar results were obtained using at least two
separate preparations of each protein. 
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ACAPs Function as Arf6 GAPs In Vivo
 
Given the localization and effects of the ACAPs, Arf6
seemed a likely substrate for these Arf GAPs. Arf6 func-
tions in the cell periphery and has well-documented effects
on the actin cytoskeleton. Because HeLa cells have been
used as a model system for a large part of this work on
Arf6 (Radhakrishna et al., 1996; Frank et al., 1998; Song et
al., 1998), we used HeLa cells to test for an effect of the
ACAPs on Arf6 function in vivo (Figs. 8 and 9). First, we
examined whether overexpression of an ACAP would af-
fect the formation of actin-rich membrane protrusions.
These structures are observed acutely in cells overexpress-
ing Arf6 upon treatment with tetrafluoroaluminate (AlF4),
as can be seen in Fig. 8 (top right, arrowhead). Coexpres-
sion of Arf6 with either ACAP inhibited the formation of
protrusions in response to AlF4 treatment (Fig. 8, second
and third rows, right). We quantified the proportion of
cells making protrusions in each case compared with those
formed in cells expressing Arf6 alone. As shown in Fig. 9,
ACAP1 was most effective at inhibiting protrusions.
ACAP2 reduced the number of cells generating protru-
sions by 50%. The effects of ACAP1 and ACAP2 were de-
pendent on GAP activity. Point mutants of the ACAPs
that lacked GAP activity had much less of an effect than
did the wild-type ACAPs (Fig. 9, and see Fig. 11, third
row). Although ASAP1 was recruited to the cell edge and
membrane protrusions, colocalizing with Arf6, it had little
or no effect on protrusions formed in the presence of Arf6
and AlF4 (Fig. 8, bottom row, and Fig. 9).
We also assessed the localization of the ACAPs with re-
spect to Arf6 in cotransfected cells. In untreated cells, al-
though ACAP1 and ACAP2 were primarily cytosolic,
they could be observed on tubular portions of the Arf6 en-
dosomal compartment (Fig. 8, arrows), and also at the
plasma membrane on small protrusive buds where they
colocalized with Arf6 (Fig. 8). With AlF4 treatment, re-
cruitment of ACAPs to this tubular endosome was greatly
enhanced, and Arf6 could also be observed on these tubes
that persisted during AlF4 treatment (Fig. 8, arrows).
These endosomal tubes were often oriented towards re-
gions along the edges of the cells where protrusions would
ordinarily form (Fig. 8, third row, two right images, arrow-
heads). Recruitment to this portion of the Arf6 endosome
was not dependent upon ACAP overexpression, since en-
dogenous ACAP2 was recruited into protrusions and
small tubular structures feeding into protrusions induced
by AlF4 in cells overexpressing Arf6-HA (Fig. 10, arrow-
head and arrow). The recruitment of ACAP1 and ACAP2
was dependent on the presence of Arf6-GTP. ACAP1 re-
mained cytosolic and was not recruited to the endosome
or the plasma membrane in cells expressing the dominant-
Figure 4. PIP2 and PA dependence of ACAP/ASAP family Arf
GAPs. Arf6 was used as a substrate for ACAP1 and ACAP2.
Arf1 was used as a substrate for 0.2 mg/ml ASAP1 purified from
bovine brain. PIP2 concentrations are indicated. The reactions
contained 380 mM PA, where indicated. The rates are given in
hydrolyses/min.
Figure 5. A conserved arginine in ACAP/ASAP family mem-
bers is necessary for GAP activity. epitope-tagged ACAP1,
[R448Q]ACAP1, ACAP2, [R442Q]ACAP2, ASAP1, and
[R497K]ASAP1 were expressed and purified as described in Ma-
terials and Methods. The GAP activity of ACAP1 and ACAP2,
using Arf6 as a substrate, was compared with the GAP activity of
an equal amount of [R448Q]ACAP1 and [R442Q]ACAP2. The
GAP activity of ASAP1 and [R497K]ASAP1, present at equiva-
lent concentrations, was determined using Arf1 as a substrate.
The data were normalized to the activity of wild-type protein,
which was 0.05/min for ACAP1, 0.088/min for ACAP2, and 0.35/
min for ASAP1. The error bars represent the range of duplicate
determinations from one of three experiments. 
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negative Arf6, T27N, even in the presence of AlF4 (Fig.
11, top row). In cells expressing the constitutively active
mutant of Arf6, Q67L, the ACAP1 (Fig. 11, middle row)
could be observed localized to the plasma in the absence
of AlF4 treatment. A point mutant of ACAP1 that lacked
GAP activity was not observed on the tubular endosomes,
but rather was associated with the plasma membrane pro-
trusions (Fig. 11, bottom row). Similar results were ob-
served with ACAP2 (not shown). Taken together, these
data are consistent with ACAP1 and ACAP2 functioning
as Arf6 GAPs.
 
Discussion
 
We have identified two Arf GAPs, ACAP1 and ACAP2,
that are structurally and biochemically similar to two pre-
 
viously described Arf GAPs, ASAP1 and PAP, and pro-
pose that the four proteins constitute the ASAP/ACAP
family of Arf GAPs. Like ASAP1, the ACAPs functioned
in the cell periphery affecting the actin cytoskeleton. In
contrast with ASAP1, ACAPs specifically affected Arf6-
dependent events. These results support the hypothesis
that Arf GAPs can discriminate between Arfs at a given
location. Given that ACAP1 and ACAP2 occur together
in a single cell, we propose that the Arf6-specific ACAPs
may discriminate between particular Arf6-dependent ac-
tivities. Site- and Arf specificity would enable Arf GAPs
to function together in coordinating a set of cellular events
leading to a biological response.
Data base searches for proteins homologous to ASAP1
led to the identification of the widely expressed ACAPs.
The proteins were similar to ASAP1 and PAP in having a
coiled-coil domain, followed by PH, Arf GAP, and ANK-
repeat domains and had GAP activity that was stimulated
by the coordinate action of PA and PIP2. Based on these
criteria, we propose that ACAP1, ACAP2, PAP, and
ASAP1 constitute a family. The ASAP/ACAP family pro-
teins are found primarily in multicellular organisms and are
involved in reorganization of the actin cytoskeleton. As a
class of proteins, these Arf GAPs could regulate processes,
such as cell migration, adhesion, and cell–cell contact, that
are important for development and wound healing.
The data provided here support the idea that GAPs
functioning at the plasma membrane can distinguish be-
tween class I/II Arfs and the class III Arf6. During PDGF
stimulation of NIH 3T3 cells, ACAP1, ACAP2, and
ASAP1 colocalized in dorsal ruffles and at the edge of
resting and protrusive HeLa cells. However, these effects
were mediated by different Arfs. In vitro ACAP1 and
ACAP2 used Arf6, relative to Arf1 and Arf5, better than
Figure 6. Ectopically expressed ACAPs in PDGF-stimulated
NIH 3T3 fibroblasts. NIH 3T3 cells expressing epitope-tagged
ACAP1, [R448Q]ACAP1, ACAP2, and [R442Q]ACAP2 were
treated for 4 min with PDGF, fixed, and immunostained. Actin
was visualized with rhodamine–conjugated phalloidin. Ruffles
are indicated by arrowheads. Bars, 10 mm.
Figure 7. ACAPS inhibit the formation of PDGF-induced dorsal
actin–rich ruffles in NIH 3T3 fibroblasts. The fraction of cells
forming dorsal ruffles in response to PDGF was determined in
cells transfected with either empty vector or vectors directing ex-
pression of the indicated ACAPs, including point mutants,
[R448Q]ACAP1 and[R442Q]ACAP2, that lack GAP activity.
The data presented are the mean 6 SEM of five experiments. 
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did ASAP1. In vivo, both ACAPs affected Arf6-depen-
dent cytoskeleton events in HeLa cells, whereas ASAP1
had no effect even though it colocalized with Arf6 at the
plasma membrane and in protrusions. Thus, in cells,
ACAPs are Arf6-specific GAPs, whereas ASAP1 affects
either a class I or II Arf. Arf1 could be the class I Arf that
ASAP is affecting, since Arf1 has been implicated in focal
adhesion formation. Taken together, these results suggest
that Arf6 may cooperate with a second Arf to regulate ac-
tin cytoskeleton reorganization.
ACAP1 and ACAP2 both affected Arf6-dependent pro-
cesses, yet were present together in a single cell. Both
ACAPs were recruited to and stabilized membrane tu-
bules. These peripheral tubules in HeLa cells represent
the site where Arf6 is activated to Arf6-GTP, a prerequi-
site for membrane recycling back to the plasma membrane
(Radhakrishna and Donaldson, 1997). Once at the plasma
membrane, accumulation of Arf6-GTP induces the forma-
tion of protrusions (Radhakrishna et al., 1996). Here,
ACAP1 was more efficient at blocking protrusions than
was ACAP2. Conversely, ACAP2 was more efficient at in-
hibiting cell spreading in NIH 3T3 fibroblasts (Nie, Z., and
Randazzo, P.A., unpublished). ACAP1 and ACAP2 may
function as a complementary pair, similar to GCS1 and
Figure 8. Effect of ACAPs on Arf6-dependent protrusions and tubules in HeLa cells. Cells were transfected with plasmids directing ex-
pression of Arf6 and epitope-tagged ACAPs. 24 h later, cells were treated as indicated and prepared for immunofluorescence. Protru-
sions are indicated by arrowheads and membrane tubules by arrows. Bars, 10 mm. 
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GLO3 in yeast (Poon et al., 1999), that are able to discrim-
inate between particular Arf6-dependent events. The rea-
son for having two Arf6 GAPs present in a single cell may
be that their functions are not strictly equivalent. With the
proper assays, we may be able to identify which GAPs are
specific for distinct Arf6-mediated events, such as adipsin
secretion (Millar et al., 1999), GLUT4 trafficking (Yang
and Mueckler, 1999), phagocytosis (Zhang et al., 1998),
rac trafficking (Radhakrishna et al., 1999), and protrusion
formation (Radhakrishna et al., 1996).
Regulation of the ASAP/ACAP family of Arf GAPs is
likely to be multifaceted to allow discrimination and coor-
dination of events within a pathway. Preliminary analysis
of phospholipid activation indicates that all ASAP/ACAP
family Arf GAPs are dependent on regulation by PIP2
and PA. However, the PH domains of the ACAPs do have
significant similarity to the phosphatidylinositol 3,4,5-
 
triphosphate (PI3,4,5P3)–binding PH domain of centaurin
 
a
 
 (Blader et al., 1999) (21% identity), with conservation of
residues in the NH
 
2
 
-terminal, a potential lipid-binding site
(32% identity over residues 269–305 of ACAP1). There-
fore, a more thorough comparison of the effects of inosi-
tide isomers on ACAPs is needed, particularly for PI3,4P2,
PI3,5P2, and PI3P, and is the subject of additional studies
(Jackson, T.R., manuscript in preparation). Other signal-
ing pathways could also impinge on the ASAP/ACAP
family of Arf GAPs. The possible role of phosphatidic
acid has been previously discussed (Liscovitch and Cant-
ley, 1995; Randazzo, 1997a,b; Toker, 1998; Kam et al.,
2000). Yet to be examined are protein interactions medi-
ated by the proline-rich and SH3-domains of PAP and
ASAP1 and the ANK repeats of all members of this fam-
ily. The crystal structure of a fragment of PAP has re-
vealed that the ANK repeats physically associate with the
Arf GAP domain (Mandiyan et al., 1999), and, therefore,
could influence the activity of this domain. Since ANK re-
peats occur in all the ASAP/ACAP family Arf GAPs, as
well as in the GIT/CAT family of Arf GAPs, this domain
could provide a common mechanism to regulate GAP ac-
tivity. A combination of specificity of protein interactions
and differences in phosphoinositide specificity in activat-
ing the GAP could provide independent regulation of
each Arf GAP.
Several molecular mechanisms by which Arf GAPs may
affect the actin cytoskeleton have been or are being con-
sidered. The ASAP/ACAP Arf GAPs are multidomain
proteins that could have one or more roles. One possibility
is that the GAPs are negative regulators through which
multiple signals converge to control Arf-GTP levels. In
this way, the effects of Arf could be coordinated with the
effects of other proteins that mediate changes in the actin
cytoskeleton, such as the Rho family proteins. An alterna-
tive model is that, in addition to the role as a negative reg-
ulator of Arf, the Arf GAPs are scaffolds, bringing pro-
teins with direct effects on the cytoskeleton together. If
any of the protein interactions were affected by Arf-GTP
binding, the GAP could have an active role, functioning as
an Arf effector. There is also evidence that Arf GAPs can
directly interact with actin, affecting depolymerization
(Blader et al., 1999). The similarity of the ACAPs to oligo-
phrenin-1, a Rho GAP identified by genetic analysis of
X-linked mental retardation (Billuart et al., 1998), raises
the additional possibility that Arf and Rho family proteins
can independently affect a common pathway.
Figure 9. Quantitation of the effect of ACAPs on Arf6-depen-
dent formation of protrusions. Cells were transfected with Arf6,
and the indicated ACAP/ASAP family Arf GAP was treated
with AlF4 for 30 min and fixed. The data are presented as the
fraction of cells forming protrusions when coexpressing the indi-
cated Arf GAP, normalized to the fraction of cells expressing
Arf6 alone, that formed protrusions. Means 6 SEM for four ex-
periments are presented.
Figure 10. Endogenous
ACAP2 associates with Arf6-
dependent tubes and protru-
sions. After a 30-min treat-
ment with AlF4, HeLa cells
expressing Arf6-HA were
stained with an antibody for
ACAP2. Bar, 10 mm. 
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Our data suggest that activated Arf6 can recruit ACAP1
and ACAP2 to membranes. We found ACAPs colocalized
with the constitutively active form [Q67L]Arf6, but not
with a dominant-negative [T27N]Arf6. The effects of AlF4
on the localization of the ACAPs to tubular endosomes
are also consistent with recruitment by Arf-GTP, since
previous studies have demonstrated that Arf6 must be
converted to Arf6-GTP on the endosome to allow mem-
brane recycling back to the plasma membrane (PM)
(Radhakrishna and Donaldson, 1997).
The striking recruitment of ACAPS to the Arf6 tubular
endosome upon AlF4 treatment raises the possibility that
AlF4 may be stabilizing an Arf6–AlF4–GAP complex,
analogous to those found for Ras and its GAPs in vitro
(Mittal et al., 1996). In such a complex, AlF4 would oc-
cupy the position normally taken by the 
 
g
 
-phosphoryl
group of GTP in the transition state of the GTPase reac-
tion. In other words, the complex of the GDP bound form
of Arf, AlF4 and GAP, mimics the complex of Arf-GTP
with GAP. If we assume that AlF4 can form such a com-
plex in cells, then, in AlF4- treated cells overexpressing
Arf6, endogenous GAP would be locked in an unpro-
ductive complex and the excess Arf6-GTP would be able
to interact with effectors, generating protrusions. Con-
versely, coexpression of GAP would sequester this excess
Arf6 in a transition state complex, blocking protrusion for-
mation. GAP mutants lacking the catalytic arginine are
unable to form this transition state, and, therefore, AlF4
treatment would be predicted to fail to form such a com-
plex. Consistent with this, AlF4 treatment of cells overex-
pressing Arf6 and mutant ACAPs did not result in recruit-
ment of GAPs to tubules. Whether or not this AlF4
complex formation is the mechanism for “activation” of
Arf6 observed in our cells will need to be tested. Interest-
ingly, for Arf1, we have detected an Arf1–GDP–AlF4–
ASAP1 complex in vitro (Randazzo, P.A., Miura, K., and
Nie, Z., manuscript in preparation)
Although we have examined the role of ACAPs in the
cell periphery, other Arf GAPs function here as well.
GIT1 was recently shown to use Arf6 as a substrate (Vi-
tale et al., 2000); Premont et al. (1998) showed that over-
expression of GIT1 inhibited trafficking of the ligand acti-
vated 
 
b
 
-adrenergic receptor into a clathrin-dependent
internalization pathway. Additionally, both ASAP1 and
the putative Arf GAP p95Pkl have been found associated
with focal adhesions (Turner et al., 1999; Randazzo et al.,
2000a). ASAP1, Pkl, and PAP have been found to bind
paxillin (Turner et al., 1999; Kondo et al., 2000). ASAP1,
Figure 11. Effects of ACAPs are depen-
dent on both the formation of Arf-GTP
and GAP activity. Cells were transfected
with either plasmids directing expression
of the dominant-negative (T27N) form or
the constitutively active (Q67L) form of
Arf6 and ACAP1. Cells expressing Arf6
and [R448Q]ACAP1, which lacks GAP
activity, were treated with AlF4 for 30 min
before preparation for immunofluores-
cence. Bars, 10 mm. 
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PAP, and GIT1 have been implicated in the regulation of
cell movement (Bagrodia et al., 1999; Kondo et al., 2000;
Randazzo et al., 2000a). Understanding how these differ-
ent Arf GAPs could function together to coordinate com-
plex cellular activities will be a key area of future research.
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